Dexamethasone 50-02-2 [email protected]

Dexamethasone (2).jpg Product Name: Dexamethasone CAS: 50-02-2 MF: C22H29FO5 MW: 392.46 EINECS: 200-003-9 Product Categories: Active Pharmaceutical Ingredients;Antitumors for Research and Experimental Use;Biochemistry;Hydroxyketosteroids;Steroids;Intermediates & Fine Chemicals;Pharmaceuticals;Isotope Labeled Compounds;Steroid and Hormone;Pharmaceutical intermediate;API;MAXIDEX;Hormone Drugs;Mainly used for anti-inflammatory and allergy;Pharmaceutical intermediates;pharmaceutical intermediate and medicine grade Mol File: 50-02-2.mol Dexamethasone is a potent synthetic member of the glucocorticoid class of steroid drugs. It acts as an anti-inflammatory and immunosuppressant. Dexamethasone (5).jpg ITEMS STANDARD RESULTS Characteristics A White or practically white, odorless, crystalline powder Conforms Specific rotation +75°~+80° +76° Purity 98% to 99.9% 99.1% Identification A. IR Conforms B. UV Conforms Chromatographic impurity Total impurities ≤2.0% Any impurities ≤1.0% conforms Residue on ignition ≤0.2% conforms Loss on drying ≤0.5% 0.1% Organic volatile impurities Meets the requirements conforms Particle size Micronized conforms Adrenocorticotropic hormone drugs, anti-inflammatory, anti-allergic and anti-drug more effective than prednisone, and promoting the removal of potassium sodium retention is very light, intramuscular or intravenous pituitary - adrenal strong inhibition: 1. Anti-inflammatory effects: The product can reduce and prevent tissue response to inflammation, thereby reducing inflammation performance. Hormone suppression of inflammatory cells, including leukocytes and macrophages accumulation in sites of inflammation and inhibition of phagocytosis, lysosomal enzyme release and synthesis and release of inflammatory chemical mediators. Can reduce and prevent tissue response to inflammation, thereby reducing inflammation performance. 2. Immunosuppressive effect: preventing or inhibiting cell-mediated immune response, delayed hypersensitivity reactions, reducing T lymphocytes, monocytes, eosinophils, reducing immunoglobulin binding to cell surface receptors and inhibition of the synthesis and release of interleukin, thus reducing the T lymphocyte transformation of lymphoblastoid cells, and reduce the extension of the primary immune response. Can reduce immune complexes through the basement membrane, and can reduce the concentration of ingredients complement and immunoglobulins.